Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
Trending
- Association trains farmers on agroforestry, carbon opportunities
- Nigerian SMEs boost growth via digital payments, investments
- Benin residents urge quick completion of Ramat park flyover
- NCoS launches new PPP committee for infrastructure projects
- Osun residents seek alternatives amid gas price surge
- Lagos police nab woman over human trafficking of Kaduna girls
- Jigawa techs call for vocational skills support
- Oyo assembly cancels anniversary celebrations over security concerns
